Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,271
Featured
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: San Francisco CA, Los Angeles CA, Iowa City IA, Toronto,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07287150
Phase2, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
for
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer,
Location: San Francisco CA, Stanford CA, Duarte CA,
Sponsor: Hoffmann-La Roche
Sex: Female
Age: 18+
Code: NCT04802759
Phase1, Phase2, Recruiting
Featured
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
for
Hemophilia A
Location: San Francisco CA, Vallejo CA, Orange CA
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07226206
Phase1, Phase2, Recruiting
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Walnut Creek CA, San Jose CA, Fresno CA, Long Beach CA,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Walnut Creek CA, San Jose CA, Modesto CA, Fresno CA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
for
Episodic Migraine
Location: Walnut Creek CA, San Jose CA, Long Beach CA, Anaheim CA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05711394
Phase3, Recruiting
FeaturedNew
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Walnut Creek CA, Concord CA, Greenbrae CA, Santa Ana CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase2, Recruiting
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Walnut Creek CA, San Diego CA, Portland OR,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase3, Recruiting
Featured
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
for
Diabetic Macular Edema
Location: Walnut Creek CA, Beverly Hills CA, Peoria AZ,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07425522
Phase1, Recruiting
Featured
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Redwood City CA, Santa Clarita CA, Lancaster CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Palo Alto CA, San Mateo CA, Sunnyvale CA, Burbank CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase3, Recruiting
Featured
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
for
Breast Cancer
Location: Palo Alto CA, Anaheim CA, Pierre SD, Mitchell SD,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07405801
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Palo Alto CA, Dallas TX, Nashville TN, Valhalla NY
Sponsor: AbbVie
Sex: All
Age: 0 - 17
Code: NCT07306832
Phase1, Recruiting
Featured
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
for
Non-cystic Fibrosis Bronchiectasis,
Location: Palo Alto CA, Kansas City KS, Birmingham AL,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06603246
Phase1, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Palo Alto CA, Sacramento CA, Boise ID, Portland OR,
Sponsor: AbbVie
Sex: All
Age: 2 - 11
Code: NCT06461897
Phase3, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Santa Rosa CA, West Hills CA, Beverly Hills CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase2, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Oakland CA, San Francisco CA, San Leandro CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & ResponsiveNew
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Oakland CA, Memphis TN, Knoxville TN, Pittsburgh PA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT07621614
Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Oakland CA, San Francisco CA, Madera CA, Los Angeles CA,